問卷

TPIDB > Principal Investigator

Principal Investigator



更新時間:2023-09-19

程廣義Cheng, Kuang-I
  • Principal Investigator
  • Clinical Trial Experience (year) 23 years 9 個月

篩選

List

4Cases

2024-03-31 - 2026-06-30

Phase II

Active
A Phase II clinical study to evaluate the efficacy and safety of APC101 in patients with Postherpetic Neuralgia over the head and neck
  • Condition/Disease

    Postherpetic Neuralgia over the head and neck

  • Test Drug

    spary

Participate Sites
3Sites

Recruiting3Sites

2024-03-31 - 2025-03-31

Phase II

  • Condition/Disease

  • Test Drug

Participate Sites
2Sites

Terminated2Sites

2010-07-01 - 2011-09-30

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
10Sites

Terminated10Sites

2015-03-01 - 2017-05-31

Phase III

AN ASIAN, PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED 14-WEEK STUDY OF DS-5565 IN PATIENTS WITH POST-HERPETIC NEURALGIA FOLLOWED BY A 52-WEEK OPEN-LABEL EXTENSION
  • Condition/Disease

    POST-HERPETIC NEURALGIA

  • Test Drug

    DS-5565

Participate Sites
14Sites

Terminated14Sites